Aptimmune Biologics is a leading biotechnology company based in Champaign, IL, specializing in the development of innovative vaccines for economically challenging swine diseases. Their proprietary Barricade platform technology enables the creation of valuable, safe, and effective vaccines, with a current focus on African Swine Fever virus (ASF) and autogenous mucosal vaccines for Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and Influenza A virus in swine (IAV-S).
With a strong emphasis on disease protection, Aptimmune Biologics is at the forefront of combating swine pathogens through their novel vaccination technology. The company has received recognition and funding for their groundbreaking work, including partnerships with industry leaders and awards such as Iowa Biotech's Top Company Award. Aptimmune Biologics is dedicated to revolutionizing disease prevention in the swine industry and continues to drive innovation in the field.
Generated from the website